Search Results

You searched for : LatestPharmaNewsDec11

	Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
	Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID with Cipla Bristol Myers Squibb today announced that its wholly-owned subsidiary, Celgene, and Cipla have settled their litigation related to patents for REVLIMID.... Dec 11
	Alembic Pharmaceuticals announces USFDA Final Approval for Asenapine Sublingual Tablets Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults.... Dec 11
	Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability ... Dec 11
	ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left.... Dec 11
5 Matching result(s) found!

-Advertisements-

Trending Now
	Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
	International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
	The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
	Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
	Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
	In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
	Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
	Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
	10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
	Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
	The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
	Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
	A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
	The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
	ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
	The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
	Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
	Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
	AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
	Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024

Search Results

Bristol Myers Squibb Receives Positive CHMP Opinion for Inrebic for Adult Patients with Myelofibrosis

Bristol Myers Squibb Announces Settlement of U.S. Patent Litigation for REVLIMID with Cipla

Alembic Pharmaceuticals announces USFDA Final Approval for Asenapine Sublingual Tablets

Merck Receives Positive EU CHMP Opinion for KEYTRUDA as First-Line Treatment for Metastatic Microsatellite Instability

ViiV Healthcare announces positive CHMP opinion for Rukobia, for the treatment of adults with multidrug-resistant HIV

Trending Now